On June 10, 2020, the team from Vanguard teamed up with Canna Advisors and Rymedi to once again welcome hundreds of guests from around the globe for another episode of our webinar series on forthcoming FDA regulation, and GMP compliance for domestic market and export-readiness in the hemp extraction, processing, and manufacturing industry...
Titled, PRODUCTIZATION FOR DOMESTIC & GLOBAL MARKETS, this second-in-series episode explored the ins-and-outs of managing the supply chain to produce formulated, retail-ready cannabis and hemp-based products.
The panel-format webinar featured leading North American and Global manufacturers of cannabinoid enriched products and ingredients, providing viewers the opportunity to ‘hear it from the field’ as the group unpacked some of the most high-barrier challenges the industry faces in the global expansion of cannabis-derived ingredients and formulated products. The webinar featured our hosts, Matthew Anderson (Vanguard Scientific ) and Dr. Jason Cross (Rymedi), along with panelists Andres Fajardo Luna (Clever Leaves), Will Corbitt (Avient Biosciences), and Jay Czarkoswki (Canna Advisors). The lively and engaging conversation explored topics including:
Supply-Chain requirements through the lens GAAP, GACP, cGMP and euGMP
Ingredient and Product Labeling Requirements for Global Off take Readiness
Product Market(s) Fit : Extraction Variances to Meet Consumer Demand
Understanding the CPG Buyer, Requirements and Restrictions
Identifying High-Performing Product Categories and Assuring Your Process is Flexible
Best Practices and Learned from Experience Process Discussions
During this session, you’ll hear high-level experts who are responsible for the success of multinational cannabis and hemp companies share the invaluable experiences and learning lessons that have helped some of the industries most successful businesses introduce cannabinoid products throughout the Americas and the European markets.
The effort, dubbed "FDA Future Proofing" centres around a four-part webinar series featuring star-studded casts of industry experts sharing actionable insights to prepare industry participants for success under federal regulation and export-focussed operation.
If you were in attendance, you'll surely be eager to know more about our speakers and their thought leadership. If you missed it, make sure you get on the pre-registration list for the next one, and take this opportunity to meet our panel and hosts (below).
Jay Czarkowski is an influential cannabis entrepreneur, investor, and advocate. A well-connected and respected industry insider, Jay and his team have helped build cannabis businesses in 30 states and internationally. As Founding Partner at Canna Advisors, Jay forges new avenues in the legal cannabis market with informed agility and strategic sophistication. A foremost authority on real estate development and cultivation design, Jay has held a commercial general contractor license since 2002. Working on multiple cannabis design projects throughout the U.S., Canada, and Puerto Rico, Jay focuses on highly automated, sustainable facilities with a niche in the greenhouse sector. Known for applying proven business tactics to unchartered territory, Jay has created a diverse vendor network at Canna Advisors with high-profile partners and serves on the board of multiple cannabis businesses. With a decade of regulatory experience as a consultant and award-winning operator, Jay has paved the way for innovative startups and technologies. He is dedicated to building the industry through successful and inclusive state programs, pairing grassroots advocacy with a global vision. In constant pursuit of new business horizons, Jay looks forward to shaping cannabis policy and growing the market internationally.
Jay is a Founding Member of the NCIA, a sustaining member of SSDP, and a Lifetime Member of the Arcview Investment Group. In 2016, he received the Arcview Group’s Outstanding Member award for his career service to the industry.
William (Will) Corbitt is the quality and compliance director for pharma-grade trailblazers, Avient Biosciences, a CBD extraction company based in North Carolina. As a seasoned quality systems and auditing professional, Will has more than four decades in GMP and FDA-compliant finished product packaging for companies ranging from startups to large, multi-site, multi-national biotech, pharmaceutical, and medical device companies, overseeing the production of all imaginable form factors. With a unique and thorough understanding of FDA regulatory landscape, Will’s vast quality systems and lean six sigma experience has seen him in roles ranging from CEO and quality director to head of compliance investigations, including work directly overseeing complaints, holds, rejections (OOS, and OOT), deviations, root cause analysis (RCA), CAPA’s, change control, quality audits, annual product reviews, manufacturing batch record reviews, and product final release. Mr. Corbitt has worked with the likes of Burroughs Wellcome, Glaxo Wellcome, GlaxoSmithKline, Pfizer, Novartis, Roche, Genentech, Bayer (now Grifols), Apotex, Cardinal Health and Regenxbio.
Andres Fajardo is an established leader and consultant who has worked with top management firms to solve key strategic issues across various industries. In his role as President and Chief Operating Officer at Clever Leaves, he has led the development of the company's GACP certified cultivation facility, the design and construction of a GMP certified extraction and formulation plant, and the development of a number of associated consumer brands. Prior to Clever Leaves, Andres was a Co-Founder & Managing Partner Founding of mojo Ventures, a unique late-stage company builder focusing on working with startups and small companies to achieve unprecedented growth and profitability. Before being an entrepreneur, Andres was President/CEO at IQ Outsourcing, a leading Colombian Business Process Outsourcing Firm that is part of the Sanford Group of Companies. Prior to joining IQ, Andres was a Principal Member at Booz & Company, a management consulting firm, based in Mexico City. Andres holds an MBA from the Harvard Business School, a B.S. in Industrial Engineering, and a B.S. in Economics from Los Andes University in Colombia.
Dr. Jason Cross (Ph.D., JD) is Co-Founder and Chief Strategy Officer for Rymedi, a technology company enabling healthcare companies to capture, track and share data with blockchain, IoT and AI. Prior to Rymedi, Dr. Cross was a professor of innovation and entrepreneurship law, policy, and business at Duke University, where he was founding Executive Director of the Innovation & Technology Policy Lab. At the ITPLab, he led the